+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Nebulizer Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797898
The global nebulizer market value was USD 0.97 billion in 2022, driven by the increasing prevalence of respiratory diseases across the globe. The market size is anticipated to grow at a CAGR of 7.1% during the forecast period of 2023-2031 to achieve a value of USD 1.79 billion by 2031.

Nebulizer: Introduction

Nebulizers are medical devices designed to convert liquid medication into a fine mist or aerosol, which can be easily inhaled by patients suffering from respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. They play a crucial role in the effective administration of inhaled medications, allowing for better drug deposition and absorption in the lungs. The global nebulizer market comprises various types of nebulizers, including jet nebulizers, ultrasonic nebulizers, and mesh nebulizers.

Nebulizer Market Scenario

The global nebulizer market has experienced significant growth in recent years, driven by factors such as the increasing prevalence of respiratory diseases, an aging population, and growing awareness of the importance of efficient respiratory care. Additionally, advancements in nebulizer technologies, the development of portable and user-friendly devices, and supportive regulatory policies have contributed to the market's expansion.

North America: The largest market for nebulizers, driven by factors such as the high prevalence of respiratory diseases, advanced healthcare infrastructure, and a strong focus on research and development.

Europe: The second-largest market, with increasing demand for nebulizers due to a growing awareness of the importance of respiratory care and a supportive regulatory framework.

Asia Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of respiratory diseases, and growing investments in healthcare infrastructure.

Nebulizer Market Segmentations

Market Breakup by Product Type

  • Jet Nebulizer
  • Ultrasonic Nebulizer
  • Mesh Nebulizer

Market Breakup by Portability

  • Digital Nebulizer
  • Analog Nebulizer

Market Breakup by Applications

  • COPD
  • Cystic Fibrosis
  • Asthma
  • Others

Market Breakup by End User

  • Hospitals
  • Clinics
  • Homecare Settings
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Nebulizer Market

Some key trends of the market are as follows:
  • Development of portable and user-friendly devices: There is an increasing demand for portable, lightweight, and easy-to-use nebulizers, particularly among elderly patients and those with limited mobility, driving market growth
  • Advancements in nebulizer technologies: The development of innovative nebulizer technologies, such as vibrating mesh nebulizers, has improved the efficiency, reliability, and convenience of drug delivery, contributing to market expansion
  • Growing emphasis on home healthcare: The increasing focus on home healthcare and the need for efficient respiratory care devices outside of clinical settings have resulted in higher demand for nebulizers
Nebulizer Market Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Adherium
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Cohero Health, Inc
  • GSK Group of Companies
  • Teva Pharmaceutical Industries Limited
  • Vectura Group Ltd
  • Propeller Health
  • Novartis AG
  • OPKO Health Inc
  • AptarGroup, Inc.,
  • Sensirion AG

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nebulizer Market Overview
3.1 Global Nebulizer Market Historical Value (2016-2022)
3.2 Global Nebulizer Market Forecast Value (2023-2031)
4 Global Nebulizer Market Landscape
4.1 Global Nebulizer Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nebulizer Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Portability
4.2.3 Analysis by Applications
5 Global Nebulizer Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nebulizer Market Segmentation
6.1 Global Nebulizer Market by Product Type
6.1.1 Market Overview
6.1.2 Jet Nebulizer
6.1.3 Ultrasonic Nebulizer
6.1.4 Mesh Nebulizer
6.2 Global Nebulizer Market by Portability
6.2.1 Market Overview
6.2.2 Digital Nebulizer
6.2.3 Analog Nebulizer
6.3 Global Nebulizer Market by Applications
6.3.1 Market Overview
6.3.2 COPD
6.3.3 Cystic Fibrosis
6.3.4 Asthma
6.3.5 Others
6.4 Global Nebulizer Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Homecare Settings
6.4.5 Others
6.5 Global Nebulizer Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Nebulizer Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Nebulizer Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Nebulizer Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Nebulizer Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Nebulizer Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Adherium
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 AstraZeneca
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Boehringer Ingelheim International GmbH
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cohero Health, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 GSK Group of Companies
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Teva Pharmaceutical Industries Limited
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Vectura Group Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Propeller Health
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Novartis AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 OPKO Health Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 AptarGroup, Inc.,
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Sensirion AG
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Nebulizer Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Pricing Models and Strategies (Additional Insight)
21.1 Overview
21.2 Cost Model
21.2.1 Manufacturing Cost Analysis
21.2.2 Procurement Cost Analysis
21.2.3 Clinical Trial Cost Factors
21.3 Pricing Strategies
21.3.1 Competitor Pricing Analysis
21.3.2 Key Assessment of Product Attributes
21.3.3 Pricing Benchmark

Companies Mentioned

  • Adherium
  • Astrazeneca
  • Boehringer Ingelheim International GmbH
  • Cohero Health, Inc.
  • Gsk Group of Companies
  • Teva Pharmaceutical Industries Limited
  • Vectura Group Ltd.
  • Propeller Health
  • Novartis AG
  • Opko Health Inc.
  • Aptargroup, Inc.
  • Sensirion Ag



Table Information